Carrier Screening Market Size - By Type (Expanded Carrier Screening, Targeted Disease Screening), By Technology (DNA Sequencing, PCR), By Medical Condition (Pulmonary Conditions, Neurological Conditions), By End-use (Hospitals), & Forecast, 2024 – 2032
Published Date: August - 2024 | Publisher: MIR | No of Pages: 240 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationCarrier Screening Market Size - By Type (Expanded Carrier Screening, Targeted Disease Screening), By Technology (DNA Sequencing, PCR), By Medical Condition (Pulmonary Conditions, Neurological Conditions), By End-use (Hospitals), & Forecast, 2024 – 2032
Carrier Screening Market Size
Carrier Screening Market size was valued at around USD 2 billion in 2023 and is anticipated to grow at a CAGR of over 13.1% between 2024 and 2032. Increasing awareness towards possibility of a genetic risks among couples, rise in adoption of cost-effective technologies for carrier screening, along with growing emphasis on early diagnosis of genetic diseases are expected to drive the industry growth over the forecast period.
People with specific ethnicities or geographic backgrounds are more prone to be at risk of specific disorders. For instance, the American College of Obstetricians and Gynecologists (ACOG) recommends carrier screenings to parents from certain ethnicity such as the French-Canadian or Cajun descent for Tay-Sachs disease. Moreover, rise in adoption of carrier screening procedures and surging consumer interest towards personalized medicines are other factors anticipated to propel the carrier screening market expansion.
Carrier screening is a genetic testing that involves testing a sample of saliva, blood, or tissue from inside of the cheek. It is used to determine whether a healthy person is a carrier of a genetic disease. The healthcare professionals highly recommend couples to get this test done to check if they are at risk of having an offspring who is affected by any type of genetic complication.
| Report Attribute | Details |
|---|---|
| Base Year | 2023 |
| Carrier Screening Market Size in 2023 | USD 2 Billion |
| Forecast Period | 2024 to 2032 |
| Forecast Period 2024 to 2032 CAGR | 13.1% |
| 2032 Value Projection | USD 6 Billion |
| Historical Data for | 2018 to 2022 |
| No. of Pages | 190 |
| Tables, Charts & Figures | 428 |
| Segments covered | Type, Technology, Medical Condition, End-use and Region |
| Growth Drivers |
|
| Pitfalls & Challenges |
|
Carrier screening for genetic diseases is among the widely established part of preconception and prenatal care especially in the developed world. Though carrier screening tests has long history, the industry has relatively limited regulatory guidelines available for providers leading to inconsistent practices. For example, countries including U.S., UK, Australia, and Canada have different guidelines for screening of cystic fibrosis carriers during pregnancy. Further, high cost of tests and lack of skilled professionals are predicted to impede the product adoption rate, thereby hampering the market growth over the analysis period.
COVID-19 Impact
The COVID-19 outbreak threw a wrench in the carrier screening industry back in 2020. Governments around the world locked down countries to contain the virus. This took a toll on healthcare, including genetic testing. Labs were forced to shut down, and non-emergency medical services were put on hold. The supply lines were all messed up, and there were shortages of everything. And to top it all off, genetic counselors weren't initially considered essential healthcare providers. It was a rough time for the industry. But as things slowly started to get back to normal, the carrier screening market started to pick up again. People were finally able to get the testing they needed, and the industry saw a big jump in growth.
Carrier Screening Market Trends
Increasing prevalence of genetic disorders, rise in maternal age resulting in pregnancy complications and increase in awareness level for presence of genetic risks in people with medical history are anticipated to augment the industry growth over the forecast timeframe. Owing to such factors, there is a growing need for proper, precise, and early diagnosis of genetic disorders among young couples in reproductive age group. Thus, if one or both the parents belong to certain ethnicities that are at high risk of genetic complications, the doctor may likely to recommend carrier screening for such couples.
Carrier Screening Market Analysis
Based on type, the carrier screening market is segmented into targeted disease carrier screening and expanded carrier screening. The expanded carrier screening segment accounted for majority revenue share in 2022 and is expected to reach around USD 3.7 billion in 2032. This is primarily attributed to the fact that it is used in screening of multiple genetic disorders irrespective of the person's ethnic background. Expanded carrier screening panels use different type of new high-throughput technologies such as microarrays and sequencing. Additionally, launch of novel products is further anticipated to boost the segmental growth.
Think of the gene sequencing market like a big pizza. It's divided into different slicesPCR, microarrays, DNA sequencing, and a few more. Out of these, DNA sequencing is the biggest slice, worth about $637 million last year. Why is DNA sequencing so popular? Well, scientists have developed some fancy new tools, like next-generation sequencing (NGS) and chromosomal microarrays. These tools let us look at a person's entire genome, kind of like a detailed map of all their genes. This is super helpful for understanding all sorts of things about a person's health. For example, it can help us find rare diseases or predict how someone will respond to certain treatments. So, as more and more people use these advanced techniques, the DNA sequencing market is expected to keep growing bigger and bigger.
Based on medical condition, the market is segregated into hematological conditions, neurological conditions, pulmonary conditions, and others. Pulmonary conditions segment dominated the carrier screening market in terms of revenue and was valued at USD 679 million in 2022. Carrier screening is majorly used for detection of different pulmonary conditions primarily for cystic fibrosis. It is an inherited disease caused due to mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
Imagine you're at the doctor's office, getting tested for a genetic condition. Who do you think conducts this test? Hospitals, reference labs, clinics, or some other place? Well, in the world of carrier screening, hospitals are the big players. They've got the equipment and the expertise to handle all kinds of genetic tests. That's why they had the most earnings last year and are expected to keep growing strong into the future. Why do people choose hospitals for carrier screening? Lots of reasons. First, hospitals offer a wide variety of genetic tests. Second, they're getting better and better at explaining these tests to patients. Third, with all the genetic diseases out there, more people are getting tested. And finally, hospitals have the top doctors and nurses to help you understand your test results.
The United States has been a powerhouse in the carrier screening industry, leading the global market. This dominance is predicted to continue, with the market expected to surpass $2.3 billion by 2032. Several factors contribute to this success. One is the high investment in research and development for genetic disorders. Another is the availability of a broad range of carrier screening tests. The United States also has a large population and a strong demand for genetic testing. This includes prenatal testing for pregnant women and newborn screening for babies. The growing popularity of direct-to-consumer genetic testing is another major factor driving the growth of this market. The result is a huge potential market for carrier screening in North America, with a vast population base and increasing awareness about genetic disorders.
Carrier Screening Market Share
Few of the leading players operating in the carrier screening market include
- Fulgent Genetics Inc.
- Thermo Fisher Scientific Inc.
- BGI Genomics
- InVitae Corporation
- Quest Diagnostics Inc.
- Illumina Inc.
- Myriad Genetics, Inc.
The market is fragmented in nature, with leading players, regional and local companies, along with start-ups improving the industry competition. The leading market players are involved in strategic developments including novel product launch, research and development, collaborations, to improve their market positioning and revenue generating capabilities.
Carrier Screening Industry News
- In February 2023, Fulgent Genetics, Inc. launched its expanded carrier screening panel, New Beacon787. This panel includes a total of 787 genes related to autosomal recessive and X-linked conditions. Such developments are expected to boost the company's revenue generating prospects and improve its business presence.
- In June 2022, Kindbody, a U.S. based, fertility service provider announced the acquisition of Phosphorus Labs, a reference laboratory. This strategic development will add carrier screening and genetic testing capabilities in company's end-to-end care delivery model.
Carrier screening market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2018 to 2032, for the following segments
Click here to Buy Section of this Report
By Type
- Expanded Carrier Screening
- Predesigned Panel Testing
- Customized Panel Testing
- Targeted Disease Carrier Screening
By Technology
- DNA Sequencing
- Polymerase Chain Reaction
- Microarrays
- Others
By Medical Condition
- Pulmonary Conditions
- Hematological Conditions
- Neurological Conditions
- Others
By End-use
- Hospitals
- Reference Laboratories
- Physician Offices & Clinics
- Others
The above information is provided for the following regions and countries
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Poland
- Sweden
- The Netherlands
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Indonesia
- Philippines
- Vietnam
- Latin America
- Brazil
- Mexico
- Argentina
- Columbia
- Peru
- Chile
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Turkey
- Israel
- Iran
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy